Bengaluru, July 10 -- The shares of this Pharmaceutical company gained 5 percent in today's trading session after the company received Board approval for a rights issue of 13,98,463 fully paid-up equity shares.

With a market capitalization of Rs 704.41 crore, the shares of Kilitch Drugs (India) Ltd were trading at Rs 438.00 per share, increasing around 3.99 percent as compared to the previous closing price of Rs 421.20 apiece.

Looking forward to the company's financial performance, revenue increased by 36 percent from Rs 45 crore in Q4FY24 to Rs 61 crore in Q4FY25. Further, during the same time frame, net profit increased by 150 percent from Rs 4 crore to Rs 10 crore.

Also read: Solar stock jumps after it plans to sell 2.4% stake in it...